(MedPage Today) — Two dose levels of maintenance treatment with extended-release buprenorphine (Sublocade) improved opioid abstinence in patients with high-risk opioid use disorder (OUD), a randomized trial showed.
After two buprenorphine injections…
Kim Atienza celebrates daughter Eliana graduating UPenn as summa cum laude, social justice awardee
Eliana Atienza was also a joint recipient of the Elaine Simon Award for Commitment to Social Justice in the City...






